AK MPJE key terms

The state regulatory body that licenses pharmacists, interns, and technicians, adopts regulations governing pharmacy practice, and investigates complaints that may lead to discipline. It operates under Alaska statute and its adopted regulations.

The credential issued by the Alaska Board of Pharmacy authorizing a person to practice pharmacy in the state. It must be current and unexpired to dispense, counsel, or supervise pharmacy personnel.

A registration allowing a student enrolled in an approved pharmacy program to gain practical experience under pharmacist supervision. Interns may perform pharmacist functions only under that supervision and within limits set by regulation.

The credential required for a person to assist in pharmacy practice tasks such as data entry, counting, and labeling. Technicians work under pharmacist supervision, and their permitted duties and ratios are defined by Board rule.

The periodic process by which a pharmacist, intern, or technician maintains active licensure by submitting an application, fee, and required continuing education before the expiration date. Practicing on a lapsed license is unlawful.

The minimum number of approved credit hours a licensee must complete during each renewal cycle, sometimes including mandated topic hours such as law or opioid education. Noncompliance can block renewal or trigger discipline.

A license that has passed its expiration date without renewal. Practicing while lapsed is unlicensed practice, and reinstatement may require additional fees, CE, or Board action depending on how long it has been expired.

The federal classification of drugs into Schedules I through V based on abuse potential and accepted medical use. Schedules drive prescribing limits, refill rules, recordkeeping, and security obligations under both federal and Alaska law.

The federal registration a pharmacy or prescriber must hold to handle controlled substances. It is separate from state licensure, and a practitioner generally needs both a valid state license and a DEA registration to prescribe or dispense.

A credential issued under DEA rules that lets a prescriber sign and transmit Schedule II prescriptions electronically. The pharmacy must verify the signature and retain the electronic record in a compliant system.

A prescription for a drug with high abuse potential and accepted medical use. Federal rules generally bar refills, require a written or qualifying electronic prescription, and impose limits on emergency oral orders that must be followed up in writing.

Dispensing less than the full quantity authorized on a controlled substance prescription. Federal rules permit partial filling of Schedule II prescriptions in defined circumstances, with remaining quantities subject to strict time limits and documentation.

A written authorization letting another person, such as an agent or the pharmacist-in-charge, order Schedule II controlled substances on behalf of the registrant. The document must be signed and kept with the registration records.

An ongoing, running record of controlled substances received, dispensed, and on hand, updated with each transaction. It allows the pharmacy to reconcile actual stock against records and detect losses or diversion promptly.

A complete count of all controlled substances on hand, taken at least every two years as required by federal regulation. It must be dated, signed, and retained, and newly registered pharmacies take one at the start.

The obligation to create and retain documents such as prescriptions, inventories, invoices, and dispensing logs for the periods set by federal and state law. Records must be readily retrievable for inspection by regulators.

The process of moving a prescription's remaining refills from one pharmacy to another at the patient's request. Federal rules permit transfers between pharmacies for most controlled substances, with specific documentation and one-time limits for Schedule III through V.

The prescriber's permission, stated on the original prescription, for the pharmacy to dispense additional quantities without a new order. Refills are prohibited for Schedule II and limited for Schedule III and IV drugs.

The documentation a pharmacy must keep for each prescription, including patient, drug, directions, quantity, prescriber, date, and dispensing pharmacist. It supports recalls, audits, and regulatory inspection.

The mandatory information that must appear on a dispensed prescription container, such as patient name, drug name and strength, directions, quantity, pharmacy, prescriber, and required cautions. Alaska rules may add state-specific items.

The pharmacist's discussion with the patient or caregiver about proper use, storage, interactions, and precautions for a dispensed medication. It is a required part of dispensing unless the patient declines or an exception applies.

The oversight a licensed pharmacist provides over interns, technicians, and pharmacy operations, including verification of prescriptions and final product checks. The degree of direct versus general supervision is set by Board rule.

The pharmacist designated as responsible for a pharmacy's day-to-day compliance, including recordkeeping, security, staffing, and adherence to laws and rules. The PIC is accountable to the Board for the pharmacy's operations.

The obligation to store drugs, especially controlled substances, in a secured area with limited access and to protect the premises against theft and diversion. Alaska rules address locks, alarms, and access control.

The duty to notify DEA and state authorities when controlled substances are discovered missing, lost, or stolen, using the required form and timeframe. Prompt reporting and documentation of the investigation are expected.

The statutory reasons the Board may suspend, revoke, or restrict a license, such as unprofessional conduct, fraud, substance impairment, or practicing beyond scope. Discipline may also include fines, probation, or remedial education.

Behavior falling below the standards expected of a licensee, often defined by statute and rule. Examples include dishonesty, practicing while impaired, failing to maintain records, or aiding unlicensed practice.

The pharmacist's independent clinical and ethical decision-making in the patient's interest, free from coercion by employers or others. It underlies duties like counseling, refusing to fill questionable prescriptions, and resolving conflicts.

Preparing a customized medication by combining, diluting, or altering ingredients for a specific patient's need. Federal and state rules govern equipment, ingredients, records, and whether a prescription or outsourcing arrangement is required.

Preparing injectable or other sterile products using aseptic technique in a controlled environment. Standards address cleanliness, personnel training, environmental monitoring, and stability, with stricter rules for higher-risk preparations.

The date after which a compounded preparation should no longer be used, based on stability, storage conditions, and risk level. It is assigned by the compounder and must be documented and placed on the label.

Pharmacy services provided within a hospital, nursing facility, or similar licensed setting, where drugs are dispensed for administration to inpatients. Rules address drug distribution systems, floor stock, and pharmacist oversight.

A drug distribution system in which medications are packaged in single doses for individual patients, often in carts or automated cabinets. It improves accuracy and accountability and is common in institutional settings.

A complimentary unit of a drug provided by a manufacturer for patient use rather than sale. Federal rules limit who may possess and distribute samples, and pharmacies must document receipt and dispensing where permitted.